Indian Consensus Guidelines for the Diagnosis and Management of Aplastic Anemia
Indian Journal of Hematology and Blood Transfusion · 2026-11 · 42 (6) · 2187-2207
DOI: 10.1007/s12288-026-02565-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Indian Journal of Hematology and Blood Transfusion, online erschienen am 27.08.2026. Verfasst von Tuphan Kanti Dolai und 31 weiteren Autor:innen. Beteiligte Einrichtung: Hematology department, Nilratan Sircar Medical College and Hospital, Kolkata, West Bengal India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aplastic anemia (AA) is a rare, potentially life-threatening disorder characterized by immune-mediated destruction of hematopoietic stem cells, resulting in a hypocellular bone marrow and cytopenias. Patients typically present with fatigue, infections, and bleeding due to anemia, neutropenia, and thrombocytopenia. Diagnosis is established by demonstrating bone marrow hypocellularity with cytopenias and is classified using the modified Camitta et al. criteria. Compared to the Western world, AA occurs more frequently in Asian populations and at a relatively younger age at presentation. Acquired AA is primarily immune-mediated, involving cytotoxic T-cell destruction of CD34⁺ stem cells and cytokine-mediated suppression of hematopoiesis. Most cases are idiopathic, while secondary causes include infections, drugs, toxins, radiation, immune disorders, and pregnancy. Diagnosis of acquired AA requires exclusion of inherited bone marrow failure syndromes and screening for paroxysmal nocturnal hemoglobinuria (PNH) clones. Diagnosis of idiopathic AA requires careful exclusion of IBMFS and other causes of pancytopenia through detailed clinical assessment and bone marrow examination. It also involves cytogenetic and molecular studies along with screening for PNH clones. Management depends on disease severity, patient age, and donor availability. Hematopoietic stem cell transplantation (HSCT) from a matched sibling donor remains the preferred curative option in eligible patients, whereas immunosuppressive therapy with anti-thymocyte globulin and cyclosporine, often combined with eltrombopag, is recommended for patients ineligible for HSCT. Supportive care is essential for all the patients. These consensus guidelines provide evidence-based recommendations for the diagnosis and management of AA, including severity classification, evaluation for PNH clones, and exclusion of IBMFS. They also address the diagnostic approach and management principles of IBMFS while outlining contemporary treatment strategies such as immunosuppressive therapy and hematopoietic stem cell transplantation, with an emphasis on data from India and other resource-limited settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hematology department, Nilratan Sircar Medical College and Hospital, Kolkata, West Bengal India.
- Christian Medical College, Vellore, Tamil Nadu India.
- Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
- ESIC Medical College & Hospital, Faridabad, Haryana India.
- King George's Medical University, Lucknow, Uttar Pradesh India.
- Postgraduate Institute of Medical Education and Research, Chandigarh, India.
ORCID-Profile: Tuphan Kanti Dolai
Zitieren
APA
Dolai, T. K., Ghosh, K., George, B., Roy, S., Kar, R., Chatterjee, T., Verma, S. P., Malhotra, P., Kushwaha, R., Singh, A. I., Mishra, K., Singh, G., Ray, S. S., Panigrahi, A., Nath, U. K., Jajodia, E., Panda, T., Mahapatra, M., Mishra, D. K., …, & Jena, R. K. (2026). Indian Consensus Guidelines for the Diagnosis and Management of Aplastic Anemia. Indian Journal of Hematology and Blood Transfusion, 42(6), 2187-2207. https://doi.org/10.1007/s12288-026-02565-7
Vancouver
Dolai TK, Ghosh K, George B, Roy S, Kar R, Chatterjee T, et al. Indian Consensus Guidelines for the Diagnosis and Management of Aplastic Anemia. Indian Journal of Hematology and Blood Transfusion. 2026;42(6):2187-2207. doi:10.1007/s12288-026-02565-7
BibTeX
@article{Dolai2026,
author = {Dolai, Tuphan Kanti and Ghosh, Kaustav and George, Biju and Roy, Shipla and Kar, Rakhee and Chatterjee, Tathagata and Verma, Shailendra Prasad and Malhotra, Pankaj and Kushwaha, Rashmi and Singh, Anil Irom and Mishra, Kundan and Singh, Gurmeet and Ray, Siddhartha Sankar and Panigrahi, Ashutosh and Nath, Uttam Kumar and Jajodia, Ekta and Panda, Tribikram and Mahapatra, Manoranjan and Mishra, Deepak Kumar and Aggarwal, Mukul and Kapoor, Rajan and Jitani, Ankit and Bhattacharyya, Jina and Kaur, Gurpreet and Banerjee, Saswata and Damodar, Sharat and Siddharthan, Neeraj and Bhargava, Rahul and Singh, Avinash Kumar and Shanmukhaiah, Chandrakala and Pati, Hara Prasad and Jena, Rabindra Kumar},
title = {Indian Consensus Guidelines for the Diagnosis and Management of Aplastic Anemia},
journal = {Indian Journal of Hematology and Blood Transfusion},
year = {2026},
volume = {42},
number = {6},
pages = {2187--2207},
doi = {10.1007/s12288-026-02565-7}
}
EUVIMED